Package 0002-7716-01

{"route": ["INTRAVENOUS"], "spl_id": "2e3ca40c-550b-4303-991e-b6c849aec30c", "openfda": {"nui": ["N0000175664", "N0000020010"], "unii": ["2BT4C47RUI"], "rxcui": ["1723745", "1723750"], "spl_set_id": ["89bcf553-669a-40b0-a9d7-67a5c1d2f591"], "pharm_class_epc": ["Epidermal Growth Factor Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER1 Antagonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0002-7716-01)  / 50 mL in 1 VIAL, SINGLE-USE", "package_ndc": "0002-7716-01", "marketing_end_date": "20260527", "marketing_start_date": "20151124"}], "brand_name": "Portrazza", "product_id": "0002-7716_2e3ca40c-550b-4303-991e-b6c849aec30c", "dosage_form": "SOLUTION", "pharm_class": ["Epidermal Growth Factor Receptor Antagonist [EPC]", "HER1 Antagonists [MoA]"], "product_ndc": "0002-7716", "generic_name": "necitumumab", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Portrazza", "active_ingredients": [{"name": "NECITUMUMAB", "strength": "16 mg/mL"}], "application_number": "BLA125547", "marketing_category": "BLA", "marketing_end_date": "20260527", "marketing_start_date": "20151124"}